Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026knxp56ce ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Qiuling Fan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fan, Q. (2026). Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026knxp56ce
Vancouver
Fan Q. Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026knxp56ce
BibTeX
@article{Fan2026,
author = {Fan, Qiuling},
title = {Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026knxp56ce}
}
EUVIMED